Abivax says stabilization agent may support ADS price after $800 million offering pricing

Abivax SA Sponsored ADR
MNSN HOLDINGS INC

Abivax SA Sponsored ADR

ABVX

0.00

MNSN HOLDINGS INC

MNSH

0.00
  • Abivax’s underwritten $800 million ADS offering included a stabilization mandate for Leerink Partners as stabilization agent.
  • Leerink may buy or sell ADSs to support the market price above levels that might otherwise prevail on Nasdaq.
  • Stabilization is discretionary, can start or stop at any time, subject to applicable rules.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abivax SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607010836PRIMZONEFULLFEED1001210660) on July 01, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.